AVANT CEO to Present at the Needham & Company Biotechnology & Medical Technology Conference.NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (Nasdaq:AVAN) today announced that Dr. Una S. Ryan, President and Chief Executive Officer of AVANT Immunotherapeutics, Inc., will present at the Needham & Company Sixth Annual Biotechnology & Medical Technology Conference at the New York Palace
New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on Wednesday, June 13 at 8:30 am EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT . A live webcast of the 30-minute presentation will be available online at http://www.wsw.com/webcast/needham18/avan and via the Investor Information area of AVANT's website at http://www.avantimmune.com. An archive of the webcast will be available via AVANT's website for 60 days following the event. About AVANT Immunotherapeutics, Inc. AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to prevent and treat disease. AVANT has three products on the market and five of AVANT's products are in clinical development. AVANT's pipeline includes products for travelers' vaccines, global health, and pandemic pandemic /pan·dem·ic/ (pan-dem´ik) 1. a widespread epidemic of a disease. 2. widely epidemic. pan·dem·ic adj. Epidemic over a wide geographic area. n. flu needs based on AVANT's oral, rapid-protecting, single-dose and temperature stable vaccine technology. Additional information on AVANT Immunotherapeutics, Inc. can be obtained through our site on the World Wide Web: http://www.avantimmune.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion